Your browser doesn't support javascript.
loading
The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1.
Ballester-Lopez, Alfonsina; Linares-Pardo, Ian; Koehorst, Emma; Núñez-Manchón, Judit; Pintos-Morell, Guillem; Coll-Cantí, Jaume; Almendrote, Miriam; Lucente, Giuseppe; Arbex, Andrea; Magaña, Jonathan J; Murillo-Melo, Nadia M; Lucia, Alejandro; Monckton, Darren G; Cumming, Sarah A; Ramos-Fransi, Alba; Martínez-Piñeiro, Alicia; Nogales-Gadea, Gisela.
Afiliação
  • Ballester-Lopez A; Neuromuscular and Neuropediatric Research Group, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Campus Can Ruti, Universitat Autònoma de Barcelona, 08916 Badalona, Barcelona, Spain.
  • Linares-Pardo I; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Koehorst E; Neuromuscular and Neuropediatric Research Group, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Campus Can Ruti, Universitat Autònoma de Barcelona, 08916 Badalona, Barcelona, Spain.
  • Núñez-Manchón J; Neuromuscular and Neuropediatric Research Group, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Campus Can Ruti, Universitat Autònoma de Barcelona, 08916 Badalona, Barcelona, Spain.
  • Pintos-Morell G; Neuromuscular and Neuropediatric Research Group, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Campus Can Ruti, Universitat Autònoma de Barcelona, 08916 Badalona, Barcelona, Spain.
  • Coll-Cantí J; Neuromuscular and Neuropediatric Research Group, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Campus Can Ruti, Universitat Autònoma de Barcelona, 08916 Badalona, Barcelona, Spain.
  • Almendrote M; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Lucente G; Division of Rare Diseases, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
  • Arbex A; Neuromuscular and Neuropediatric Research Group, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Campus Can Ruti, Universitat Autònoma de Barcelona, 08916 Badalona, Barcelona, Spain.
  • Magaña JJ; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Murillo-Melo NM; Neuromuscular disorders Unit. Neurology Service. Neuroscience department, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.
  • Lucia A; Neuromuscular and Neuropediatric Research Group, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Campus Can Ruti, Universitat Autònoma de Barcelona, 08916 Badalona, Barcelona, Spain.
  • Monckton DG; Neuromuscular disorders Unit. Neurology Service. Neuroscience department, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.
  • Cumming SA; Neuromuscular and Neuropediatric Research Group, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Campus Can Ruti, Universitat Autònoma de Barcelona, 08916 Badalona, Barcelona, Spain.
  • Ramos-Fransi A; Neuromuscular disorders Unit. Neurology Service. Neuroscience department, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.
  • Martínez-Piñeiro A; Neuromuscular and Neuropediatric Research Group, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Campus Can Ruti, Universitat Autònoma de Barcelona, 08916 Badalona, Barcelona, Spain.
  • Nogales-Gadea G; Neuromuscular disorders Unit. Neurology Service. Neuroscience department, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.
Genes (Basel) ; 11(7)2020 07 07.
Article em En | MEDLINE | ID: mdl-32645888
The number of cytosine-thymine-guanine (CTG) repeats ('CTG expansion size') in the 3'untranslated region (UTR) region of the dystrophia myotonica-protein kinase (DMPK) gene is a hallmark of myotonic dystrophy type 1 (DM1), which has been related to age of disease onset and clinical severity. However, accurate determination of CTG expansion size is challenging due to its characteristic instability. We compared five different approaches (heat pulse extension polymerase chain reaction [PCR], long PCR-Southern blot [with three different primers sets-1, 2 and 3] and small pool [SP]-PCR) to estimate CTG expansion size in the progenitor allele as well as the most abundant CTG expansion size, in 15 patients with DM1. Our results indicated variability between the methods (although we found no overall differences between long PCR 1 and 2 and SP-PCR, respectively). While keeping in mind the limited sample size of our patient cohort, SP-PCR appeared as the most suitable technique, with an inverse significant correlation found between CTG expansion size of the progenitor allele, as determined by this method, and age of disease onset (r = -0.734, p = 0.016). Yet, in light of the variability of the results obtained with the different methods, we propose that an international agreement is needed to determine which is the most suitable method for assessing CTG expansion size in DM1.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes Genéticos / Reação em Cadeia da Polimerase / Expansão das Repetições de Trinucleotídeos / Distrofia Miotônica Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes Genéticos / Reação em Cadeia da Polimerase / Expansão das Repetições de Trinucleotídeos / Distrofia Miotônica Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article